Danske Bank upgraded Zealand Pharma (ZLDPF) to Hold from Sell with an DKK 825 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- Zealand Pharma initiated with an Overweight at JPMorgan
- Zealand Pharma’s 2024 Progress and Financial Results
- Zealand Pharma issued Complete Response Letter for dasiglucagon in CHI
- Zealand Pharma reports Breakthrough Therapy designation for survodutide
- Zealand Pharma initiated with a Hold at Deutsche Bank